Your session is about to expire
← Back to Search
Rimegepant for Migraine Prevention
Study Summary
This trial tests a new migraine prevention medicine to see if it helps people with a history of bad response to other treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My migraines last from 4 to 72 hours without treatment.I have had migraines for over a year, starting before I was 50.My migraines last from 4 to 72 hours without treatment.I've had 4 to 14 migraine days monthly in the last 3 months.I've had fewer than 15 headache days a month for the last 3 months.I've had 15 or more headache days each month for the last 3 months.My migraines last from 4 to 72 hours without treatment.I've had fewer than 15 headache days per month for the last 3 months.I have a history of severe types of headaches or migraines.I can tell the difference between my migraine and other types of headaches.I do not have any major neurological issues besides migraines.I've had fewer than 15 headache days per month for the last 3 months.I have had migraines for over a year, starting before I was 50.I've tried 2-4 types of migraine prevention pills in the last 10 years without success.I have had 4 to 14 migraine days each month for the last 3 months.I've tried more than 4 types of migraine prevention pills without success.I can tell my migraine attacks apart from other headaches and have tried 2-4 types of migraine prevention treatments that didn't work well in the last 10 years.I have a long-term pain condition like fibromyalgia.I've had 4 to 14 migraine days each month for the last 3 months.I have had migraines for over a year, starting before I was 50.
- Group 1: Rimegepant 75 mg
- Group 2: Placebo
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current sample size of participants in this research trial?
"The study's sponsor, Biohaven Pharmaceuticals Inc., requires 600 patients who meet their inclusion criteria to conduct the trial. Multiple sites will be employed for this purpose, including DM Clinical Research in Tomball Texas and Northwest Clinical Research Centre in Bellevue Washington."
Who meets the eligibility criteria for this clinical experiment?
"This clinical trial seeks 600 persons aged 18-65 who are suffering from migraines. For eligibility, applicants must have dealt with migraine episodes for at least one year prior to turning 50 years old; the length of headache bouts should range between 4 and 72 hours if not medicated; on average, there should be between four and fourteen days per month where migraine is experienced in the three months before screening; no more than fifteen headaches a month (migraine or otherwise) during those same three months and throughout the duration of the screening period is allowed; participants need to distinguish their migraine attacks from tension/cluster headaches as well as demonstrate"
How many settings are being monitored to oversee the progress of this trial?
"This clinical trial is taking place in 18 locations across the country, including Tomball, Bellevue and Miami. To reduce stress on participants, it's recommended to select a nearby center when enrolling."
What potential adverse effects should be taken into consideration when prescribing Rimegepant 75 mg?
"The safety of Rimegepant 75mg is highly rated, attaining a score of 3 due to its Phase 4 status which confirms the drug's approval."
Are there vacancies open for participation in this experiment?
"The details on clinicaltrials.gov confirm that the recruitment of this medical trial is currently underway, having been initially posted to the website at the start of November 7th 2022 and subsequently updated a day later."
Can individuals under the age of 40 partake in this research project?
"Patients should be between 18 and 65 years old to qualify for this clinical trial. There are 32 trials that provide medical treatments specifically designed for minors, while 117 studies focus on patients over the age of seniority."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Most responsive sites:
- California Neuroscience Research, LLC: < 24 hours
Average response time
- < 1 Day
Typically responds via
Share this study with friends
Copy Link
Messenger